Chronic intermittent intravenous insulin therapy (CIIIT) for type 1 diabetes mellitus
Record ID 32006001564
English
Authors' objectives:
The purpose of chronic intermittent intravenous insulin therapy (CIIIT) is to reduce symptoms, improve glycemic control, and prevent diabetic sequelae in patients with type 1 diabetes mellitus who do not respond adequately to conventional percutaneous intensive insulin therapy (IIT). CIIIT is not intended to replace IIT but rather to supplement it.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2006
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=4713
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Diabetes Mellitus, Type 1
- Drug Delivery Systems
- Insulin
- Insulin Infusion Systems
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.